IDOGEN

Idogen

Market Cap 101.8M
Today
Day High
5.20
4.89
Day Low
4.45
Day Open
5.20
Prev Close
4.90
VWAP
4.8
Volume
61K
Turnover
0.293M
Top Broker
AVA
VWAP
5.0
Avg Volume
50K
Avg Turnover
0.248M
Top Brokers
AVA/NON
VWAP
5.0
Avg Volume
59K
Avg Turnover
0.294M
Top Brokers
AVA/NON
VWAP
4.9
Avg Volume
131K
Avg Turnover
0.644M
Top Brokers
AVA/NON
52 week summary
Price Range
4.4
Last
18.2
Beta
N/A
Market Cap
101.8M
Total Return
-35.3%
Trailing P/E
N/A
Div Yield
N/A%
Shares Outstanding
20.8M
Next Earnings Date
15 Feb
Stock Exchange
Aktietorget
5 day chart Go to advanced chart

Identify and measure trend strength in stocks with our Momentum tool to identify potential entry and exit signals. The tool provides a set of the most simple but powerful indicators that identify whether a stock is under sell or buy pressure.


Relative Price Strength
Change 3 Months 1.2%
Change 12 Months -40.9%
Volume Trend
Average Volume 10 vs 60 Days -31.4%
Price VS
52 Week High -73.1%
50 Day Moving Average 1.4%
200 Day moving Average -8.2%

Add article markers

Compare Idogen to

Prev Close 0 Change 0
High 0 Avg Daily Volume 0
Low 0 Avg Daily Turnover 0
  • Management
  • Lars Hedbys, CEO
  • Executive board
  • Agneta Edberg, Chairman of the board
Source: Millistream
Major Owners Equity Votes
HCN Group AB 9.9%
9.9%
Ventac Holding (Cyprus) LTD 6.6%
6.6%
Olov Sjögren 5.6%
5.6%
Leif-Göran Salford 5.4%
5.4%
Danica Pension 70085817 4.3%
4.3%
Source: Millistream
Timeframe Transactions Net Shares
Last 12 weeks
0 Purchases
+ 0
0 Sales
- 0
Last 24 weeks
0 Purchases
+ 0
0 Sales
- 0
Report Date Name Position Transaction Shares Chg Est Value (SEK)

Catalyst Potential is behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Source: Millistream FI
  •  
  • Profitability
  • ROE
  • ROCE
  • ROIC
  • EBITDA margin
  • EBIT margin
  • Net margin
  • Per share data (SEK)
  • EPS
  • EPS adj
  • Dividend
  • Net debt
  • Total shares
  • Valuation
  • EV (SEKm)
  • P/E
  • P/E diluted
  • P/Sales
  • EV/Sales
  • EV/EBITDA
  • EV/EBIT
  • P/BV
  • Capital structure
  • Equity ratio
  • Debt/equity ratio
  • Net debt(SEKm)
  • Capital employed(SEKm)
  • Capital turnover rate
  • (SEKm)
  • Net sales
  • Total operating costs
  • EBITDA
  • Depreciation
  • Amortization
  • Impairment charges
  • EBIT
  • Share in profits
  • Net financial items
  • Exchange rate dif.
  • Pre-tax profit
  • Tax
  • Net earnings
  • (SEKm)
  • Assets
  • Current assets
  • Cash in banks
  • Receivables
  • Inventories
  • Other current assets
  • Current assets
  • Fixed assets
  • Tangible assets
  • Associated comp.
  • Investments
  • Goodwill
  • Cap. exp. for dev.
  • O intangible rights
  • O non-current assets
  • Total fixed assets
  • Deferred tax assets
  • Total (assets)
  • Liabilities
  • Current liabilities
  • Short-term debt
  • Accounts payable
  • O current liabilities
  • Current liabilities
  • Long-term debt
  • O long-term liabilities
  • Convertibles
  • Total Liabilities
  • Deferred tax liab
  • Provisions
  • Shareholders' equity
  • Minority interest (BS)
  • Minority & equity
  • Total liab & SE
  • (SEKm)
  • Net sales
  • Total operating costs
  • Depreciations total
  • EBIT
  • Taxes on EBIT
  • NOPLAT
  • Depreciation
  • Gross cash flow
  • Change in WC
  • Gross CAPEX
  • Free cash flow

Estimated Values is behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Source: Redeye
Source: Redeye

Presentations, research interviews and videos from our events listed here.


Source: Redeye